Vrbatky, Czechia

Gabriel Gonzalez

This inventor holds 1 USPTO granted patent. Top assignee: Univerzita Palackeho V Olomouci. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriel Gonzalez. Retrieved from https://idiyas.com/inventor/gabriel-gonzalez-fklkec9v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriel Gonzalez: Innovator in Neuroprotection

Introduction

Gabriel Gonzalez is a notable inventor based in Vrbátky, Czech Republic. He has made significant contributions to the field of neuroprotection through his innovative research and patents. His work focuses on developing new therapeutic compounds that can aid in the treatment of neurodegenerative diseases.

Latest Patents

Gabriel Gonzalez holds a patent for "Terpenoid derivatives, pharmaceutical preparations containing these derivatives and their use in neuroprotection." This patent highlights the potential of terpenoid derivatives in medicinal applications, particularly for their selective anti-neurodegenerative properties on neuronal cells and tissues. These compounds are particularly promising for the treatment and prophylaxis of diseases such as Parkinson's and Huntington's disease.

Career Highlights

Gonzalez is affiliated with Palacký University Olomouc, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential impact on the medical field, especially in neuroprotection.

Collaborations

Some of his notable coworkers include Milan Urban and Jirí Hodon, who have collaborated with him on various research projects. Their combined expertise contributes to the advancement of knowledge in the field of neuroprotection.

Conclusion

Gabriel Gonzalez is a pioneering inventor whose work in terpenoid derivatives holds great promise for the future of neurodegenerative disease treatment. His contributions to the field are invaluable and continue to inspire further research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…